Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Leukemia, Lymphocytic, Chronic, B-Cell × Imatinib Mesylate × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Philadelphia Chromosome 2 Translocation, Genetic 1 Recurrence 1 Pathologic Processes 1 Neoplasms by Histologic Type 1 Leukemia, Myeloid 1 Leukemia 1 Hematologic Diseases 1 Bronchiolitis Obliterans Syndrome 1 Bone Marrow Diseases 1

Interventions

Rituximab 6 venetoclax 5 Bendamustine Hydrochloride 5 obinutuzumab 3 acalabrutinib 3 zanubrutinib 2 pirtobrutinib 2 idelalisib 2 ibrutinib 2 Chlorambucil 2 umbralisib 1 ublituximab 1 ofatumumab 1 fludarabine phosphate 1 duvelisib 1 atezolizumab 1 Pharmacogenomic Testing 1 Cyclophosphamide 1 CT-P10 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡